Cetus/Centocor patent settlement
Executive Summary
Cetus drops patent infringement suit against Centocor in connection with monoclonal antibody/septic shock patent application owned by the Velos Group and licensed to Centocor. Under the terms of the agreement, Centocor retains the license and will offer a sublicense to Cetus on terms to be negotiated. The suit was filed in San Francisco Federal Court in July 1987.